Uncategorized

Biotech pauses trial after second patient death linked to gene therapy – The Washington Post

Posted on Author Tim Hodges Comments Off on Biotech pauses trial after second patient death linked to gene therapy – The Washington Post
  1. Biotech pauses trial after second patient death linked to gene therapy  The Washington Post
  2. Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne  Sarepta Therapeutics
  3. UPDATE: Second Patient Dies After Receiving Sarepta’s DMD Gene Therapy Elevidys  BioSpace
  4. Roche Pauses Commercial and Clinical Use of Elevidys After Fatal Liver Failures  WSJ
  5. After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry  statnews.com